Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
about
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsTherapeutic implications of the gender-specific aspects of cardiovascular disease.Racial susceptibility for QT prolongation in acute drug overdoses.Using a Model to Design Activity-Based Educational Experiences to Improve Cultural Competency among Graduate Students.
P2860
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@ast
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@en
type
label
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@ast
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@en
prefLabel
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@ast
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@en
P356
P1476
Male/female differences in pharmacology: safety issues with QT-prolonging drugs.
@en
P2093
Marietta Anthony
P356
10.1089/JWH.2005.14.47
P577
2005-01-01T00:00:00Z